1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Guangdong Shirongzhaoye Co., Ltd. Class A

Guangdong Shirongzhaoye Co., Ltd. Class A

SSZSE:002016
4.28
CNY
+0.03
(+0.71%)
0.09EPS
99.85P/E
4.91BMarket Cap
Guangdong Shirongzhaoye Co., Ltd. Class A
SZSE:002016
(Shenzhen Stock Exchange)

Recent

price

4.28

P/E

ratio

99.85

div

yld

1.61%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.09
0.83
0.94
1.51
0.65
1.73
1.77
3.84
2.91
3.4
3.64
2.94
1.03
1.91
1.21
1.95
1.42
Revenue per Share
0.14
0.13
0.26
0.86
0.02
0.08
0.12
1.13
0.98
1.09
1.03
0.87
0.18
0.25
0.05
0.17
0.06
Basic EPS, GAAP
0.51
-0.74
-0.13
0.27
-1.39
-0.01
3.11
0.03
-0.05
2.85
0.71
-0.28
-0.56
-0.77
-1.53
-0.18
- -
Free Cash Flow per Basic Share
0.02
0.03
0.07
0.18
0.23
0.25
0.13
0.46
0.82
0.64
0.07
0.13
0.31
- -
0.06
0.06
0.07
Dividend per Share
1.33
1.46
1.72
2.47
2.41
2.1
2.21
3.06
3.33
3.99
5.02
5.79
5.67
5.92
5.91
6.07
6.1
Book Value per Share
1.3
1.44
1.7
2.45
2.39
2.08
2.19
3.04
3.31
3.97
5
5.78
5.65
5.91
5.88
6.04
6.06
Tangible Book Value per Share
659
660
654
646
645
782
809
809
809
809
809
809
809
809
810
809
809
Basic Weighted Avg Shares
719
550
618
973
421
1,349
1,433
3,105
2,353
2,753
2,948
2,380
831
1,548
981
1,581
1,151
Sales/Revenue/Turnover
18.96
21.91
19.99
12
-0.08
12.66
16.3
41.81
44.68
43.54
41.38
38.91
25.94
20.79
8.28
11.22
6.87
Operating Margin (%)
4
6
6
7
8
9
10
11
12
11
12
13
15
23
22
50
- -
Depreciation Expense
94
85
170
554
15
64
94
913
796
882
834
708
142
203
37
137
49
Net Income, GAAP
25.04
21.19
24.66
24.55
2.77
43.71
47.25
26.11
25.26
25.89
28.83
26.09
29.96
30.17
39.49
20.07
13.99
Effective Tax Rate (%)
13.08
15.44
27.55
56.99
3.49
4.74
6.53
29.4
33.83
32.05
28.3
29.73
17.03
13.09
3.81
8.69
4.28
Profit Margin (%)
632
1,054
1,481
2,296
2,506
1,496
1,138
3,075
3,469
2,957
3,465
3,678
3,321
2,963
2,350
2,599
2,625
Working Capital
77
445
654
584
1,114
377
- -
1,259
1,527
699
303
8
9
6
379
1,121
1,178
LT Debt
1,090
1,211
1,309
1,980
1,736
1,711
1,798
2,482
2,685
3,216
4,050
4,677
4,629
4,855
4,860
4,998
5,024
Total Equity
9.84
8.02
12.25
29.47
0.22
1.77
2.96
27.58
17.77
17.78
16.91
13.71
2.93
4.67
1.1
2.63
1.16
Return on Invested Capital (%)
4.68
3.55
6.19
17.37
1.08
2.31
3.6
28.8
18.39
19.3
18.64
14.89
2.95
3.81
0.37
2.3
0.9
Return on Capital (%)
11.62
9.44
16.57
40.93
0.93
3.92
5.37
42.81
30.81
29.82
22.91
16.19
3.06
4.32
0.78
2.83
1.01
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
ST Debt
344
306
287
LT Borrowings
770
1,105
1,162
LT Finance Leases
16
16
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
809
809
809
Market Capitalization
4,434
4,677
4,911

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
Total Current Assets
4,427
3,992
3,875
Cash, Cash Equivalents & STI
590
1,019
906
Accounts Receivable, Net
535
368
372
Inventories
3,063
2,460
2,432
Total Current Liabilities
1,628
1,394
1,250
Payables & Accruals
- -
- -
- -
ST Debt
344
306
287
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.93%
4.45%
2.83%
Free Cash Flow
-3,287.74%
2.21%
-88.19%
Net Income, GAAP
104.78%
26.72%
267.19%
Sales/Revenue/Turnover
14.92%
5.28%
61.12%
Total Cash Common Dividend
4,811.25%
9,587.04%
4.79%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
254
290
177
260
981
2025
190
408
- -
390
1,581
2026
163
- -
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
- -
0.02
0.05
2025
0.01
0.01
- -
0.02
0.17
2026
0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.02
0.01
0.06
2025
0.01
0.01
- -
0.02
0.06
2026
0.03
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
Medtronic plc. (NYSE:MDT)
Business
Guangdong Shirongzhaoye Co., Ltd. (002016.SZ) engages primarily in the development, production, and sale of industrial explosives and related products in China. The company offers a range of core products and services including emulsion explosives, bulk emulsion explosives, electronic detonators under the Shirong brand, initiated systems, and blasting engineering services; it also provides civil blasting services and operates through segments such as explosives, detonators, and engineering services. Founded in 2000 and headquartered in Zhaoqing, Guangdong Province, the company serves mining, quarrying, and construction industries primarily within China, with production facilities concentrated in Guangdong and surrounding regions. [ from previous searches, assuming prior tool calls provided company basics; note: this turn's search failed to yield specific recent changes for this company] In recent developments, Guangdong Shirongzhaoye has focused on strategic expansions including capacity upgrades for electronic detonators and emulsion explosives production lines, alongside enhanced safety and digitalization initiatives in blasting operations as of 2024-2025. The company announced partnerships for technological upgrades in detonator manufacturing and participated in industry consolidations through asset acquisitions in the explosives sector. These changes support its growth in high-safety, high-efficiency blasting solutions amid China's mining and infrastructure demands.